Matsumura I - Search Results

1

[Therapeutic choice for the chronic myeloid leukemia patients in chronic phase showing late suboptimal response to imatinib].

Matsumura I, Nannya Y, Nagai T, Tanimoto K, Fujikawa K, Kasai M, Inaguma Y, Takeuchi M, Niimi H, Kashiwagi H, Imamura Y, Yagi T, Sakamoto E, Okabe M, Aoki G, Katayama T, Okada M, Adachi Y, Saburi Y, Kizaki M. Matsumura I, et al. Rinsho Ketsueki. 2010 Dec;51(12):1762-8. Rinsho Ketsueki. 2010. PMID: 21258186 Japanese.

2

[Adult T cell leukemia/lymphoma with hyperprolactinemia: successful treatment by OK432 and PSK].

Matsumura I, Kiso S, Tago H, Kawakami F, Fushimi H, Aozasa K, Kanakura Y, Tamaki T, Kanayama Y, Yonezawa T, et al. Matsumura I, et al. Rinsho Ketsueki. 1991 Mar;32(3):266-71. Rinsho Ketsueki. 1991. PMID: 2041169 Japanese.

3

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM; ENESTnd Investigators. Saglio G, et al. N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5. N Engl J Med. 2010. PMID: 20525993 Free article. Clinical Trial.

4

[The 2nd generation of TKIs for chronic myeloid leukemia].

Matsumura I. Matsumura I. Rinsho Ketsueki. 2010 Oct;51(10):1386-94. Rinsho Ketsueki. 2010. PMID: 20962471 Japanese. No abstract available.

5

[Roles of the 2nd generation TKIs for CML].

Matsumura I. Matsumura I. Rinsho Ketsueki. 2011 Oct;52(10):1610-8. Rinsho Ketsueki. 2011. PMID: 21971238 Japanese. No abstract available.

6

[Pathogenesis and pathophysiology of chronic myeloid leukemia in chronic phase].

Hirase C, Matsumura I. Hirase C, et al. Among authors: matsumura i. Nihon Rinsho. 2012 Apr;70 Suppl 2:293-7. Nihon Rinsho. 2012. PMID: 23133970 Japanese. No abstract available.

7

[Treatment for de novo chronic myeloid leukemia in chronic phase].

Hirase C, Matsumura I. Hirase C, et al. Among authors: matsumura i. Nihon Rinsho. 2012 Apr;70 Suppl 2:298-303. Nihon Rinsho. 2012. PMID: 23133971 Japanese. No abstract available.

8

[Relationship between red blood cell transfusion volume and posttransfusional iron overload in hematological diseases].

Ashida T, Kawano A, Yamada E, Ide D, Sugano C, Kato Y, Tsubakimoto Y, Ito S, Mine Y, Fujita M, Kanemitsu Y, Morishima Y, Morita Y, Tanaka H, Shimada T, Kawanishi K, Miyatake J, Tatsumi Y, Matsumura I. Ashida T, et al. Among authors: matsumura i. Rinsho Ketsueki. 2013 Apr;54(4):365-9. doi: 10.3999/jscpt.44.365. Rinsho Ketsueki. 2013. PMID: 23666218 Japanese.

9

[Treatment of chronic myeloid leukemia in chronic phase].

Matsumura I. Matsumura I. Rinsho Ketsueki. 2014 Oct;55(10):1853-9. Rinsho Ketsueki. 2014. PMID: 25297749 Review. Japanese. No abstract available.

10

Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma.

Kobayashi T, Kuroda J, Fuchida S, Kaneko H, Yagi H, Shibayama H, Tanaka H, Kosugi S, Uoshima N, Kobayashi M, Adachi Y, Ohta K, Ishii K, Uchiyama H, Matsuda M, Nakatani E, Tsudo M, Shimazaki C, Takaori-Kondo A, Nomura S, Matsumura I, Taniwaki M, Kanakura Y; KMF investigators. Kobayashi T, et al. Among authors: matsumura i. Int J Hematol. 2015 Jan;101(1):37-45. doi: 10.1007/s12185-014-1696-6. Epub 2014 Nov 11. Int J Hematol. 2015. PMID: 25385278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters